Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer
Raquel Fernández-García, Ana I. Fraguas-Sánchez · 2024
Read Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer by Raquel Fernández-García, Ana I. Fraguas-Sánchez (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11677881.txt.
Description
Raquel Fernandez-Garcia and Ana Fraguas-Sanchez review tiny drug carriers for delivery through the lungs, in work from 2024. Breathing a drug in sends it straight to the lungs, keeping levels high at the site and sparing the rest of the body. The catch is that the airways work hard to clear inhaled particles out.
Nanomedicines can be designed to stay in the lungs longer and dodge that clearance. They also cut how much drug spreads to other tissues, which lowers side effects. The review covers their use for lung infections and for lung cancer. It sorts carrier types and the barriers each must beat to work in patients.
Catalog record
| CREATOR | Raquel Fernández-García, Ana I. Fraguas-Sánchez |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |